eIF4A1-dependent mRNAs employ purine-rich 5'UTR sequences to activate localised eIF4A1-unwinding through eIF4A1-multimerisation to facilitate translation.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
28 02 2023
Historique:
accepted: 11 01 2023
revised: 20 12 2022
received: 18 10 2022
pubmed: 3 2 2023
medline: 4 3 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

Altered eIF4A1 activity promotes translation of highly structured, eIF4A1-dependent oncogene mRNAs at root of oncogenic translational programmes. It remains unclear how these mRNAs recruit and activate eIF4A1 unwinding specifically to facilitate their preferential translation. Here, we show that single-stranded RNA sequence motifs specifically activate eIF4A1 unwinding allowing local RNA structural rearrangement and translation of eIF4A1-dependent mRNAs in cells. Our data demonstrate that eIF4A1-dependent mRNAs contain AG-rich motifs within their 5'UTR which specifically activate eIF4A1 unwinding of local RNA structure to facilitate translation. This mode of eIF4A1 regulation is used by mRNAs encoding components of mTORC-signalling and cell cycle progression, and renders these mRNAs particularly sensitive to eIF4A1-inhibition. Mechanistically, we show that binding of eIF4A1 to AG-rich sequences leads to multimerization of eIF4A1 with eIF4A1 subunits performing distinct enzymatic activities. Our structural data suggest that RNA-binding of multimeric eIF4A1 induces conformational changes in the RNA resulting in an optimal positioning of eIF4A1 proximal to the RNA duplex enabling efficient unwinding. Our data proposes a model in which AG-motifs in the 5'UTR of eIF4A1-dependent mRNAs specifically activate eIF4A1, enabling assembly of the helicase-competent multimeric eIF4A1 complex, and positioning these complexes proximal to stable localised RNA structure allowing ribosomal subunit scanning.

Identifiants

pubmed: 36727461
pii: 7023804
doi: 10.1093/nar/gkad030
pmc: PMC9976904
doi:

Substances chimiques

5' Untranslated Regions 0
Purines 0
RNA, Messenger 0
EIF4A1 protein, human 0
Eukaryotic Initiation Factor-4A EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1859-1879

Subventions

Organisme : Cancer Research UK
ID : 29256
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00025/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M01245X/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Mol Cell Biol. 1999 Jan;19(1):807-16
pubmed: 9858603
Biochemistry. 2016 Feb 16;55(6):948-59
pubmed: 26795062
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
IUCrJ. 2016 Oct 27;3(Pt 6):440-447
pubmed: 27840683
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):6304-6309
pubmed: 28559306
Nat Genet. 1999 Dec;23(4):387-8
pubmed: 10581018
Nucleic Acids Res. 2020 Sep 25;48(17):9521-9537
pubmed: 32766783
Biochim Biophys Acta. 2013 Aug;1829(8):750-5
pubmed: 23542735
Nature. 1990 Jun 7;345(6275):544-7
pubmed: 2348862
Sci Rep. 2017 Sep 20;7(1):11999
pubmed: 28931898
BMC Bioinformatics. 2010 Mar 15;11:129
pubmed: 20230624
Nat Rev Cancer. 2008 Dec;8(12):976-90
pubmed: 19029958
EMBO J. 1992 Jul;11(7):2643-54
pubmed: 1378397
J Biol Chem. 1999 Apr 30;274(18):12236-44
pubmed: 10212190
Nat Commun. 2015 Aug 11;6:7921
pubmed: 26260686
Genome Biol. 2019 Dec 30;20(1):300
pubmed: 31888698
Mol Cell. 2015 Aug 20;59(4):541-52
pubmed: 26212457
Nature. 2016 Jun 15;534(7608):558-61
pubmed: 27309803
Biochem Cell Biol. 2020 Aug;98(4):502-510
pubmed: 32008367
Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):9611-9616
pubmed: 28827335
RNA. 2012 Jul;18(7):1373-84
pubmed: 22589333
Cell Rep. 2021 Oct 12;37(2):109806
pubmed: 34644561
Clin Cancer Res. 2018 Sep 1;24(17):4256-4270
pubmed: 29844128
Int J Mol Sci. 2019 Sep 10;20(18):
pubmed: 31510048
Cancer Res. 2013 Aug 1;73(15):4674-86
pubmed: 23749641
Nat Chem Biol. 2006 Apr;2(4):213-20
pubmed: 16532013
Structure. 2017 Mar 7;25(3):469-481
pubmed: 28238534
Genome Biol. 2014;15(10):476
pubmed: 25273840
Nucleic Acids Res. 2011 Mar;39(6):2260-70
pubmed: 21062831
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13339-44
pubmed: 23901100
Mol Cell. 2007 Oct 26;28(2):304-14
pubmed: 17964268
Nat Struct Mol Biol. 2004 Apr;11(4):346-51
pubmed: 15034551
Mol Cell Proteomics. 2018 May;17(5):974-992
pubmed: 29414762
J Biol Chem. 2001 Jan 26;276(4):2872-9
pubmed: 11060291
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Mol Cell. 2016 Sep 1;63(5):865-76
pubmed: 27546789
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
pubmed: 12824337
Genome Biol. 2019 Dec 2;20(1):262
pubmed: 31791371
J Mol Biol. 2017 Nov 24;429(23):3730-3742
pubmed: 29037760
Mol Cell. 2019 Feb 21;73(4):738-748.e9
pubmed: 30595437
Biochem Soc Trans. 2015 Oct;43(5):763-72
pubmed: 26517881
J Mol Biol. 2006 Aug 25;361(4):731-43
pubmed: 16890241
Science. 2015 Jun 26;348(6242):1486-8
pubmed: 26113725
PLoS One. 2014 Jan 23;9(1):e87237
pubmed: 24466343
Nucleic Acids Res. 2011 Apr;39(7):2678-89
pubmed: 21113024
Int J Mol Sci. 2020 Feb 29;21(5):
pubmed: 32121426
Genes Dev. 2016 Jul 1;30(13):1573-88
pubmed: 27401559
Oncogene. 2006 Oct 16;25(48):6416-22
pubmed: 17041626
Nucleic Acids Res. 2014 Jul;42(12):7911-22
pubmed: 24848014
Nature. 2014 Sep 4;513(7516):65-70
pubmed: 25079319
Nucleic Acids Res. 2019 Jun 4;47(10):5260-5275
pubmed: 30997503
J Virol. 2000 Aug;74(16):7284-97
pubmed: 10906182
Translation (Austin). 2016 Jan 04;4(1):e1137381
pubmed: 27335721
Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):505-16
pubmed: 21779027
Annu Rev Biophys. 2012;41:247-67
pubmed: 22404686
Methods Mol Biol. 1999;112:531-52
pubmed: 10027275
Cell. 2009 Feb 6;136(3):447-60
pubmed: 19203580
Nucleic Acids Res. 2010 Jan;38(Database issue):D750-3
pubmed: 19854939
J Mol Biol. 2014 Jan 9;426(1):51-61
pubmed: 24080224
Cell Death Dis. 2015 Jan 22;6:e1603
pubmed: 25611378
Nature. 2019 Sep;573(7772):144-148
pubmed: 31435012
Tumour Biol. 2017 Jun;39(6):1010428317709805
pubmed: 28653885
Biol Chem. 2009 Dec;390(12):1237-50
pubmed: 19747077
J Biol Chem. 2001 Aug 17;276(33):30914-22
pubmed: 11418588
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Genes Dev. 2002 Nov 15;16(22):2906-22
pubmed: 12435632
Cell. 2020 Feb 6;180(3):411-426.e16
pubmed: 31928844
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Nature. 2018 Jul;559(7712):130-134
pubmed: 29950728
Elife. 2017 Nov 30;6:
pubmed: 29192585
BMC Struct Biol. 2018 Sep 15;18(1):12
pubmed: 30219048
J Appl Crystallogr. 2009 Apr 1;42(Pt 2):342-346
pubmed: 27630371
Biochem Soc Trans. 2015 Dec;43(6):1227-33
pubmed: 26614665
Neuro Oncol. 2016 Sep;18(9):1265-77
pubmed: 26951381
Methods. 2018 Jul 1;143:12-15
pubmed: 29410279
RNA. 2001 Mar;7(3):382-94
pubmed: 11333019
J Mol Biol. 2008 Apr 18;378(1):178-90
pubmed: 18343405
J Biol Chem. 1999 Jun 18;274(25):17677-83
pubmed: 10364207
NMR Biomed. 2008 Feb;21(2):159-64
pubmed: 17461436

Auteurs

Tobias Schmidt (T)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Adrianna Dabrowska (A)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK.
Department of Urology, University of California, San Francisco, CA 94158, USA.
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.

Joseph A Waldron (JA)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Kelly Hodge (K)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Grigorios Koulouras (G)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Mads Gabrielsen (M)

MVLS Structural Biology and Biophysical Characterisation Facility, University of Glasgow, University Avenue, Glasgow G12 8QQ, UK.

June Munro (J)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

David C Tack (DC)

Spectrum Health Office of Research and Education, Spectrum Health System, 15 Michigan Street NE, Grand Rapids, MI 49503, USA.

Gemma Harris (G)

Research Complex at Harwell, Rutherford Appleton Laboratory, Harwell Campus, Didcot OX11 0FA, UK.

Ewan McGhee (E)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

David Scott (D)

Research Complex at Harwell, Rutherford Appleton Laboratory, Harwell Campus, Didcot OX11 0FA, UK.
ISIS Spallation Neutron and Muon Source, Rutherford Appleton Laboratory, Harwell Campus, DidcotOX11 0QX, UK.
School of Biosciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington LE12 5RD, UK.

Leo M Carlin (LM)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK.

Danny Huang (D)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK.

John Le Quesne (J)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK.

Sara Zanivan (S)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK.

Ania Wilczynska (A)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK.

Martin Bushell (M)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH